drug

PRL3-ZUMAB

Phase 2updated 3mo ago

by IISG Pte Ltd

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying PRL3-ZUMAB

phase2A Study of PRL3-zumab in Neovascular Age-related Macular Degeneration (nAMD)recruitingn=15
phase2PRL3-Zumab in Patients With Advanced Solid Tumorsactive not recruitingn=60
phase2A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumorsactive not recruitingn=51
phase3Phase II/III Trial of PRL3-Zumab in Advanced Solid Tumor Patientsrecruitingn=52

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 9m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

PRL3-ZUMAB

Phase 2updated 3mo ago

by IISG Pte Ltd

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying PRL3-ZUMAB

phase2A Study of PRL3-zumab in Neovascular Age-related Macular Degeneration (nAMD)recruitingn=15
phase2PRL3-Zumab in Patients With Advanced Solid Tumorsactive not recruitingn=60
phase2A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumorsactive not recruitingn=51
phase3Phase II/III Trial of PRL3-Zumab in Advanced Solid Tumor Patientsrecruitingn=52

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 9m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

PRL3-ZUMAB

all catalysts(0)

Trials studying PRL3-ZUMAB

News(0)

Report a data issue

comments(0)

PRL3-ZUMAB

all catalysts(0)

Trials studying PRL3-ZUMAB

News(0)

Report a data issue

comments(0)